153 related articles for article (PubMed ID: 17372690)
1. Crystallization kinetics of amorphous griseofulvin by pattern fitting procedure using X-ray diffraction data.
Yamamura S; Takahira R; Momose Y
Pharm Res; 2007 May; 24(5):880-7. PubMed ID: 17372690
[TBL] [Abstract][Full Text] [Related]
2. Process induced disorder in crystalline materials: differentiating defective crystals from the amorphous form of griseofulvin.
Feng T; Pinal R; Carvajal MT
J Pharm Sci; 2008 Aug; 97(8):3207-21. PubMed ID: 17990307
[TBL] [Abstract][Full Text] [Related]
3. Fast surface crystallization of amorphous griseofulvin below T g.
Zhu L; Jona J; Nagapudi K; Wu T
Pharm Res; 2010 Aug; 27(8):1558-67. PubMed ID: 20414704
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the milling-induced thermal behavior of crystalline and amorphous griseofulvin.
Trasi NS; Boerrigter SX; Byrn SR
Pharm Res; 2010 Jul; 27(7):1377-89. PubMed ID: 20490628
[TBL] [Abstract][Full Text] [Related]
5. Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin.
Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
Mol Pharm; 2008; 5(6):927-36. PubMed ID: 19434849
[TBL] [Abstract][Full Text] [Related]
6. Toward understanding the evolution of griseofulvin crystal structure to a mesophase after cryogenic milling.
Feng T; Bates S; Carvajal MT
Int J Pharm; 2009 Feb; 367(1-2):16-9. PubMed ID: 19013224
[TBL] [Abstract][Full Text] [Related]
7. Structure determination of phase II of the antifungal drug griseofulvin by powder X-ray diffraction.
Mahieu A; Willart JF; Guerain M; Derollez P; Danéde F; Descamps M
Acta Crystallogr C Struct Chem; 2018 Mar; 74(Pt 3):321-324. PubMed ID: 29504561
[TBL] [Abstract][Full Text] [Related]
8. Characterization of monoclinic crystals in tablets by pattern-fitting procedure using X-ray powder diffraction data.
Yamamura S; Momose Y
Int J Pharm; 2003 Jun; 259(1-2):27-37. PubMed ID: 12787633
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of crystalline pharmaceuticals in tablets by pattern-fitting procedure using X-ray diffraction pattern.
Takehira R; Momose Y; Yamamura S
Int J Pharm; 2010 Oct; 398(1-2):33-8. PubMed ID: 20674727
[TBL] [Abstract][Full Text] [Related]
10. Assessment of milling-induced disorder of two pharmaceutical compounds.
Otte A; Carvajal MT
J Pharm Sci; 2011 May; 100(5):1793-804. PubMed ID: 21374615
[TBL] [Abstract][Full Text] [Related]
11. Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.
Al-Obaidi H; Lawrence MJ; Buckton G
J Pharm Pharmacol; 2016 Nov; 68(11):1373-1383. PubMed ID: 27696396
[TBL] [Abstract][Full Text] [Related]
12. Single particle nonlinear optical imaging of trace crystallinity in an organic powder.
Wanapun D; Kestur US; Taylor LS; Simpson GJ
Anal Chem; 2011 Jun; 83(12):4745-51. PubMed ID: 21598920
[TBL] [Abstract][Full Text] [Related]
13. Griseofulvin/carrier blends: application of partial least squares (PLS) regression analysis for estimating the factors affecting the dissolution efficiency.
Cutrignelli A; Trapani A; Lopedota A; Franco M; Mandracchia D; Denora N; Laquintana V; Trapani G
AAPS PharmSciTech; 2011 Dec; 12(4):1019-30. PubMed ID: 21826623
[TBL] [Abstract][Full Text] [Related]
14. Acceleration of Crystal Growth of Amorphous Griseofulvin by Low-Concentration Poly(ethylene oxide): Aspects of Crystallization Kinetics and Molecular Mobility.
Shi Q; Zhang C; Su Y; Zhang J; Zhou D; Cai T
Mol Pharm; 2017 Jul; 14(7):2262-2272. PubMed ID: 28548840
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS.
Al-Obaidi H; Buckton G
AAPS PharmSciTech; 2009; 10(4):1172-7. PubMed ID: 19842041
[TBL] [Abstract][Full Text] [Related]
16. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
[TBL] [Abstract][Full Text] [Related]
17. Quantification of compaction-induced crystallinity reduction of a pharmaceutical solid using 19F solid-state NMR and powder X-ray diffraction.
Liu J; Nagapudi K; Kiang YH; Martinez E; Jona J
Drug Dev Ind Pharm; 2009 Aug; 35(8):969-75. PubMed ID: 19360510
[TBL] [Abstract][Full Text] [Related]
18. Supercritical fluid crystallization of griseofulvin: crystal habit modification with a selective growth inhibitor.
Jarmer DJ; Lengsfeld CS; Anseth KS; Randolph TW
J Pharm Sci; 2005 Dec; 94(12):2688-702. PubMed ID: 16258994
[TBL] [Abstract][Full Text] [Related]
19. Segal crystallinity index revisited by the simulation of X-ray diffraction patterns of cotton cellulose Iβ and cellulose II.
Nam S; French AD; Condon BD; Concha M
Carbohydr Polym; 2016 Jan; 135():1-9. PubMed ID: 26453844
[TBL] [Abstract][Full Text] [Related]
20. On the polymorphism of griseofulvin: identification of two additional polymorphs.
Mahieu A; Willart JF; Dudognon E; Eddleston MD; Jones W; Danède F; Descamps M
J Pharm Sci; 2013 Feb; 102(2):462-8. PubMed ID: 23132509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
